Trademark: 88786904
Word
NEOACTT
Status
Dead
Status Code
606
Status Date
Monday, June 27, 2022
Serial Number
88786904
Mark Type
4000
Filing Date
Thursday, February 6, 2020
Published for Opposition
Tuesday, March 30, 2021
Abandoned Date
Monday, June 27, 2022

Trademark Owner History
NeoGenomics Laboratories, Inc. - Owner At Publication

Classifications
41 Providing online, non-downloadable reports for others in the fields of medical tests, medical testing, medical research, pathology, diagnostic testing, oncology testing and human disease and medical conditions
9 Downloadable webinars in the fields of health, health related topics, cancer, cancer pathology, pathology, medical testing, medical tests, diagnostic testing, oncology testing, human disease and human medical conditions; downloadable electronic publications in the nature of newsletters and abstracts in the fields of pathology, medical testing, medical tests, diagnostic testing, oncology testing, human disease and human medical conditions; downloadable software for medical testing and analysis of medical test results; downloadable software for enhanced analyzing, researching, and reviewing of medical, scientific, and genetic information, testing and analysis; downloadable computer software and related downloadable databases all for use in nucleic acid and protein assay analysis and for quality control, clinical decision support, validation, interpretation, reporting, data management, integration with medical records, physician portals, laboratory networking, professional healthcare and trial matching services all related to genomic analysis and molecular analysis
44 Medical diagnostic testing services in the field of human disease and human medical conditions; medical testing for diagnostic or treatment purposes; genetic testing for medical purposes; medical testing for diagnostic or treatment purposes; providing medical information to others in the field of human disease, human medical conditions, medical diagnostic testing services and medical testing for diagnostic or treatment purposes; providing an Internet website portal featuring medical information in the field of human disease, and human medical conditions, medical diagnostic testing services, medical testing for diagnostic or treatment purposes; medical testing for diagnostic purposes for the detection of cancer; medical testing for the detection of genetic information pertaining to human disease; medical diagnostic testing to aid in diagnosis, prognosis and therapy selection; medical testing services for diagnostic or treatment purposes provided by oncology reference laboratories
42 Medical research; genetic mapping for scientific purposes, namely, gene sequencing; genetic testing and sequencing for scientific purposes; molecular sequencing for scientific purposes; cancer study and analysis, cytometry, cytogenetics, cell analysis, cell preservation, clinical study and testing of cells all being for scientific purposes; clinical study and testing of cells for scientific or research purposes; medical and scientific research information in the field of gene sequencing, molecular sequencing, cancer study and analysis, clinical study and testing of cells; medical and scientific research in the field of gene sequencing, molecular sequencing, cancer study and analysis, cytometry, cytogenetics, cell analysis, cell preservation, clinical study and testing of cells, and cancer; providing scientific information to others in the fields of oncology, pathology and gene sequencing, molecular sequencing, cancer study and analysis, clinical study and testing of cells scientific testing and research services and clinical scientific testing; providing an internet website portal featuring gene sequencing, molecular sequencing, cancer study and analysis, clinical study and testing of cells for scientific purposes; scientific and medical research information in the fields of scientific testing and research services, medical research services, and clinical scientific testing; providing cloud-based scientific and medical research information in the nature of providing temporary use of non-downloadable cloud based software for providing information to others in the field of scientific testing and research services, medical research services, and clinical scientific testing; providing temporary use of online non-downloadable software for analysis of medical test results; temporary use of online non-downloadable software for enhancement of analysis, research, and review of information pertaining to medical, scientific, genetic, testing and analysis, and information and pertaining to such testing and analysis; software as a service (SAAS) services featuring software for analysis of medical test results; nondownloadable computer software for enhancement of analysis, research, and review of information pertaining to medical, scientific, genetic, testing and analysis, and information pertaining to testing and analysis; providing medical research and scientific research information in the field of oncology; scientific testing and research services in the field of human disease and human medical conditions; providing medical research services in the field of human disease and human medical conditions; providing clinical scientific testing services and medical research and testing for research purposes in the field of human disease and human medical conditions; clinical laboratory research services, oncology reference laboratory services for research and scientific purposes, providing medical research information and interactive scientific research information to others in the fields of medical tests, medical testing, medical research, pathology, diagnostic testing, oncology testing and human disease and medical conditions; providing cloud-based information in the nature of providing temporary use of non-downloadable cloud based software for providing information to others to others in the field of scientific testing and research, medical research, and clinical scientific testing; providing online nondownloadable Internet-based software for medical testing and analysis of medical test results; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; medical and scientific research, namely, conducting clinical trials for others; conducting research and clinical trials for others relating to medical devices and pharmaceuticals; software as a service (SAAS) services featuring software for use in nucleic acid and protein assay analysis and for quality control, clinical decision support, validation, interpretation, reporting, data management, integration with medical records, physician portals, laboratory networking, professional healthcare and trial matching services all related to genomic analysis and molecular analysis; providing cloud-based non-downloadable computer software providing medical information to others in the field of human disease, human medical conditions, medical diagnostic testing services, and medical testing for diagnostic or treatment purposes
NEO ACT

Trademark Events
Jun 27, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Jun 27, 2022
Abandonment - No Use Statement Filed
Jun 13, 2022
Teas Change Of Correspondence Received
Jun 13, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 13, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jun 17, 2021
Notice Of Approval Of Extension Request E-Mailed
Jun 16, 2021
Sou Extension 1 Granted
Jun 9, 2021
Sou Extension 1 Filed
Jun 16, 2021
Case Assigned To Intent To Use Paralegal
Jun 9, 2021
Sou Teas Extension Received
Jun 9, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Jun 9, 2021
Teas Change Of Correspondence Received
Jun 9, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 9, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jun 9, 2021
Teas Change Of Owner Address Received
May 25, 2021
Noa E-Mailed - Sou Required From Applicant
Mar 30, 2021
Official Gazette Publication Confirmation E-Mailed
Mar 30, 2021
Published For Opposition
Mar 10, 2021
Notification Of Notice Of Publication E-Mailed
Feb 25, 2021
Approved For Pub - Principal Register
Feb 24, 2021
Teas/Email Correspondence Entered
Feb 24, 2021
Correspondence Received In Law Office
Feb 24, 2021
Teas Response To Office Action Received
Dec 7, 2020
Notification Of Non-Final Action E-Mailed
Dec 7, 2020
Non-Final Action E-Mailed
Dec 7, 2020
Non-Final Action Written
Nov 16, 2020
Teas/Email Correspondence Entered
Nov 16, 2020
Correspondence Received In Law Office
Nov 16, 2020
Assigned To Lie
Oct 14, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Oct 14, 2020
Teas Change Of Correspondence Received
Oct 14, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 14, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 14, 2020
Teas Change Of Owner Address Received
Oct 14, 2020
Teas Response To Office Action Received
Apr 26, 2020
Notification Of Priority Action E-Mailed
Apr 26, 2020
Priority Action E-Mailed
Apr 26, 2020
Priority Action Written
Apr 17, 2020
Assigned To Examiner
Feb 10, 2020
New Application Office Supplied Data Entered
Feb 10, 2020
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24